SCHEMBL31205727

SCHEMBL31205727

NNc1ccnc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1782191 1.00 — —
SCHEMBL23887607 0.81 SYK (0.42) —
SCHEMBL27764814 0.78 GABRA1 (0.38) —
SCHEMBL445950 0.77 — —
SCHEMBL29909710 0.77 — —
Salicyladehyde SCHEMBL29001184 0.77 TRIM24 (0.49) —
SCHEMBL11256791 0.74 — —
SCHEMBL12998775 0.74 KDM4E (0.52) —
SCHEMBL22896965 0.74 GRM5 (0.35) —
SCHEMBL17601584 0.74 LMNA (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709723-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 — — EP disclosed
WO-2024233544-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2024-11-14 — — WO disclosed
Send feedback